祥生医疗: 无锡祥生医疗科技股份有限公司董事会战略委员会工作细则

Core Points - The article outlines the working rules of the Strategic Committee of Wuxi Xiangsheng Medical Technology Co., Ltd, emphasizing its role in the company's long-term strategic planning and major investment feasibility studies [1][2][3] Group 1: General Provisions - The Strategic Committee is established to ensure the scientific nature of the company's development planning and strategic decision-making, enhancing sustainable development capabilities [1] - The committee consists of three directors, including at least one independent director, with the company chairman serving as the committee's head [1][2] Group 2: Responsibilities and Authority - The committee is responsible for researching and proposing suggestions on the company's medium and long-term development plans, operational goals, and strategic investments [1][12] - It has the authority to review and analyze the execution of the previous year's strategic plans and suggest adjustments based on the company's actual situation [1][12] Group 3: Meeting Procedures - The committee can convene meetings as needed, with notifications sent at least three days in advance [3][6] - A quorum of two-thirds of the committee members is required for meetings to be held, and decisions are made based on majority votes [6][29] Group 4: Decision-Making and Record-Keeping - Decisions made by the committee must be documented and reported to the board of directors, with records maintained for at least ten years [39][11] - The committee's resolutions are effective upon signing by attending members, and any violations of legal or regulatory requirements may result in joint liability for participating members [41][11]